Literature DB >> 11889923

Vestibular mechanisms involved in idiopathic scoliosis.

D Manzoni1, F Miele.   

Abstract

Patients affected by idiopathic scoliosis (IS) show not only a spinal deformity, but also postural and oculomotor deficits suggesting that such syndrome can be related to a vestibular disfunction. It appears, however, that, in children, a slight unbalance in the activity of vestibular complex of both sides escapes the neuronal mechanisms responsible for vestibular compensation and leads to the spinal curvature which characterises IS. Such process could be reinforced by a disrupted integration of vestibular and visual signals at cortical level, leading to an altered perception of the vertical and to abnormal motor commands. In addition to the classical ascending and descending pathways arising from the vestibular nuclei, which utilize glutamate or GABA as neurotransmitters, labyrinthine afferents may also affect spinal, cerebellar and cerebrocortical structures, through the noradrenergic and serotoninergic systems, which originate from the locus coeruleus and the raphe nuclei, respectively. Due to the role of these neuromodulators in brain plasticity, a disruption in the activity of monoaminergic neurons could favour the development of postural and oculomotor deficits. An impaired release of monoamine at cerebrocortical level could also explain the cognitive deficits which may occur in IS patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889923

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  10 in total

1.  Eye-hand laterality and right thoracic idiopathic scoliosis.

Authors:  Jean-François Catanzariti; Marc-Alexandre Guyot; Olivier Agnani; Samantha Demaille; Elisabeth Kolanowski; Cécile Donze
Journal:  Eur Spine J       Date:  2014-03-17       Impact factor: 3.134

2.  SNTG1, the gene encoding gamma1-syntrophin: a candidate gene for idiopathic scoliosis.

Authors:  Stavros Bashiardes; Rose Veile; Missy Allen; Carol A Wise; Mathew Dobbs; Jose A Morcuende; Lazlos Szappanos; John A Herring; Anne M Bowcock; Michael Lovett
Journal:  Hum Genet       Date:  2004-04-16       Impact factor: 4.132

3.  Effect of bracing or surgical treatments on balance control in idiopathic scoliosis: three case studies.

Authors:  Jean-Philippe Pialasse; Martin Simoneau
Journal:  J Can Chiropr Assoc       Date:  2014-06

4.  Evidence for cognitive vestibular integration impairment in idiopathic scoliosis patients.

Authors:  Martin Simoneau; Vincent Lamothe; Emilie Hutin; Pierre Mercier; Normand Teasdale; Jean Blouin
Journal:  BMC Neurosci       Date:  2009-08-25       Impact factor: 3.288

5.  Assessment of sensorimotor control in adults with surgical correction for idiopathic scoliosis.

Authors:  Jean-Philippe Pialasse; Pierre Mercier; Martin Descarreaux; Martin Simoneau
Journal:  Eur Spine J       Date:  2016-02-04       Impact factor: 3.134

6.  Reconstitution of lost cervical spine function: management strategies.

Authors:  Arne Ernst; Andreas Niedeggen
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

7.  Adolescent Idiopathic Scoliosis: A 71 Cases Study Ascertaining that Straightening Is Possible, and a New Etiological Hypothesis.

Authors:  Jan Polak
Journal:  Asian Spine J       Date:  2013-11-28

8.  Asymmetric Unilateral Vestibular Perception in Adolescents With Idiopathic Scoliosis.

Authors:  Emma J Woo; Gunter P Siegmund; Christopher W Reilly; Jean-Sébastien Blouin
Journal:  Front Neurol       Date:  2019-12-03       Impact factor: 4.003

9.  Migraine vestibulopathy in three families with idiopathic scoliosis: a case series.

Authors:  Alev Uneri; Senol Polat; Onder Aydingoz; Aysegul Bursali
Journal:  Cases J       Date:  2009-12-21

10.  The Vestibular-Evoked Postural Response of Adolescents with Idiopathic Scoliosis Is Altered.

Authors:  Jean-Philippe Pialasse; Martin Descarreaux; Pierre Mercier; Jean Blouin; Martin Simoneau
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.